S&P 500 Futures
(0.25%) 5 119.25 points
Dow Jones Futures
(0.02%) 38 734 points
Nasdaq Futures
(0.66%) 17 724 points
Oil
(-0.38%) $83.04
Gas
(-0.22%) $1.808
Gold
(-0.55%) $2 329.20
Silver
(-0.68%) $27.18
Platinum
(-0.20%) $921.00
USD/EUR
(0.18%) $0.936
USD/NOK
(0.67%) $10.98
USD/GBP
(0.17%) $0.804
USD/RUB
(-0.82%) $92.43

Realtime updates for Vectura Group PLC [VEC.L]

Exchange: LSE Industry: Pharmaceuticals, Biotechnology & Life Sciences
Last Updated31 Dec 1970 @ 19:00

0.00% £ 164.80

Live Chart Being Loaded With Signals

Commentary (31 Dec 1970 @ 19:00):

Vectura Group Plc engages in the provision of pharmaceutical development. The company is headquartered in Chippenham, Wiltshire and currently employs 453 full-time employees...

Stats
Today's Volume 203 762
Average Volume 8.30M
Market Cap 0.00
EPS £-0.00834 ( 2019-06-29 )
Last Dividend £19.00 ( 2021-06-01 )
Next Dividend £0 ( N/A )
P/E 0.0800
ATR14 £0 (0.00%)

Vectura Group PLC Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Vectura Group PLC Financials

Annual 2020
Revenue: £190.60M
Gross Profit: £101.40M (53.20 %)
EPS: £0.188
Q2 2019
Revenue: £44.58M
Gross Profit: £23.83M (53.45 %)
EPS: £-0.00848
Q1 2019
Revenue: £44.58M
Gross Profit: £23.83M (53.45 %)
EPS: £-0.00848
Q1 2019
Revenue: £44.58M
Gross Profit: £23.83M (53.45 %)
EPS: £-0.00848

Financial Reports:

No articles found.

Vectura Group PLC Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)

Vectura Group PLC Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.35 - Potential for dividend initiation, but uncertain (13.08%)
Information
First Dividend £6.50 2019-10-14
Last Dividend £19.00 2021-06-01
Next Dividend £0 N/A
Payout Date 2021-06-11
Next Payout Date N/A
# dividends 2 --
Total Paid Out £25.50 --
Avg. Dividend % Per Year 0.00% --
Score 2.69 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 4.35
Div. Directional Score 8.24 --
Next Divdend (Est)
(2025-10-01)
£0 Estimate 0.00 %
Dividend Stability
0.02 Very Bad
Dividend Score
2.69
Pay Frequency
Sporadic
Yearly Payout
Year Amount Yield
2019 £0 0.00%
2020 £0 0.00%
2021 £0 0.00%
2022 £0 0.00%
2023 £0 0.00%
2024 £0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for LSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SQZ.L Dividend Knight 2023-10-26 Annually 5 3.33%
JSG.L Dividend Knight 2023-10-05 Annually 32 0.64%
CCC.L Dividend Knight 2023-09-28 Semi-Annually 26 1.57%
POLR.L Dividend King 2023-07-06 Semi-Annually 18 4.22%
GEM.L Dividend Knight 2023-04-27 Semi-Annually 3 7.30%
ALFA.L Dividend King 2023-09-14 Semi-Annually 5 3.78%
THS.L Dividend Knight 2023-06-08 Annually 7 3.10%
LTHM.L Dividend Knight 2023-08-03 Semi-Annually 33 0.87%
CPG.L Dividend Knight 2023-06-08 Annually 24 0.87%
RKT.L Dividend Knight 2023-08-03 Semi-Annually 23 1.95%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.6421.50010.0010.00[0 - 0.5]
returnOnAssetsTTM0.1841.2003.874.65[0 - 0.3]
returnOnEquityTTM0.2541.5008.2910.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM3.590.80010.008.00[1 - 3]
quickRatioTTM0.9230.8009.287.42[0.8 - 2.5]
cashRatioTTM0.9231.5005.998.98[0.2 - 2]
debtRatioTTM0.00631-1.5009.89-10.00[0 - 0.6]
interestCoverageTTM1 314.001.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM0.03802.009.9910.00[0 - 30]
freeCashFlowPerShareTTM0.01812.009.9910.00[0 - 20]
debtEquityRatioTTM0.00771-1.5009.97-10.00[0 - 2.5]
grossProfitMarginTTM0.5321.0004.474.47[0.2 - 0.8]
operatingProfitMarginTTM0.6891.00010.0010.00[0.1 - 0.6]
cashFlowToDebtRatioTTM5.901.00010.0010.00[0.2 - 2]
assetTurnoverTTM0.2860.800-1.425-1.140[0.5 - 2]
Total Score12.14

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM8.781.0009.210[1 - 100]
returnOnEquityTTM0.2542.508.9010.00[0.1 - 1.5]
freeCashFlowPerShareTTM0.01812.009.9910.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM0.03802.009.9910.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM01.500-3.330[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1301.0009.250[0.1 - 0.5]
Total Score4.35

Vectura Group PLC

Vectura Group Plc engages in the provision of pharmaceutical development. The company is headquartered in Chippenham, Wiltshire and currently employs 453 full-time employees. The firm's products include Ultibro Breezhaler (European Union (EU) and Rest of World (RoW)) - LABA-LAMA; Seebri Breezhaler (EU and RoW) - LAMA; AirFluSal Forspiro (EU and RoW) - ICS-LABA; ADVATE (Global) - Antihaemophilic Factor (Recombinant); Adept (Global) - Icodextrin; Anoro Ellipta (Global) - LAMA-LABA; Relvar Ellipta/Breo Ellipta (Global) - ICS-LABA, and Incruse Ellipta (Global) - LAMA. Its product pipeline includes VR588, VR475, VR647, VR942, VR179, VR736, VR096, VR876, VR315, VR506, VR632, Seebri Neohaler and VR465. Its dry powder inhalers (DPI) include GyroHaler, Lever-operated, Open-inhale-close and Unit Dose DPI. Its smart nebuliser delivery systems provide targeted inhalation therapy for applications where precise and targeted delivery of a drug to the lungs is needed. Its smart nebulizer delivery systems include AKITA JET and FOX.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators